The last decade or two have witnessed a plethora of newer chemotherapy drugs being approved for treating cancer, most of which have been approved based on clinical trials using the RECIST 1.1 (or the older RECIST) criteria to demonstrate efficacy of treatment and prolongation of disease-free survival. However, how accurate are the RECIST 1.1 criteria …
Continue reading How accurate is RECIST 1.1 for assessing tumor response?
